How Brave New World Is Sneaking Up On Us
By John Farrell,
Forbes
| 02. 28. 2016
Untitled Document
Paul Knoepfler is not a scientist given to alarmism, but it’s pretty clear from his informative new book that the Brave New World is already upon us.
GMO Sapiens: the Life-Changing Science of Designer Babies provides a comprehensive overview of the state of the art science, and what headline-grabbing breakthroughs we can expect in the very near future, perhaps in less than a year.
Genetically modified human embryos are likely to be implanted and brought to term in the U.K., where three-parent IVF has been approved. This is a limited form of genetic manipulation, aimed to help couples where the mother would pass on certain diseases due to faulty genes in the mitochondria, the cell’s energy centers. In the process, the nucleus of the mother’s egg cell is transferred to replace the nucleus of a donor whose own egg cells contain healthy mitochondria. In this way the couple can avoid passing on the mother’s disease bearing genes.
In China, we may see human embryos modified using the controversial new CRISPR-Cas 9 technology to bring children to term, also...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Isabel van Brugen, Newsweek | 06.05.2025
A U.S.-based biotech company has unveiled a new in vitro fertilization (IVF) option that allows parents to select embryos based on genetic markers tied to health and longevity.
DNA testing and analysis company Nucleus Genomics has announced the world's first...
By Jonathan D. Grinstein, PhD, Inside Precision Medicine | 06.03.2025
On Tuesday, 307 days after he was first admitted to Children’s Hospital of Philadelphia (CHOP), KJ Muldoon went home after being successfully treated with the first personalized CRISPR gene editing therapy. KJ, who was born with a serious and...